New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 19, 2014
09:28 EDTGMEGameStop says CEO underwent unexpected surgery for tumor
GameStop disclosed in a regulatory filing that late last week Paul Raines, its CEO, underwent unexpected surgery during which a "very small, cancerous tumor was identified and successfully removed from an easily accessible part of the brain." The company added, "Because it was found very early, his doctors have advised him that his prognosis for a full and complete recovery is very good. The next step is for Paul to undergo preventive chemotherapy. Recovery from this process is expected to take about six weeks. This regimen will restrict his travel during that period, but will not interfere with his continued leadership of the Company." Daniel DeMatteo, Executive Chairman, said, "Speaking for the Board, we have every confidence in Paulís continued leadership and wish him a speedy recovery. While he recovers, our highly-tenured executive team will ensure that our business continues without interruption."
News For GME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent GME news | >>
November 21, 2014
07:53 EDTGMEGameStop Q3 results disappointing, says RW Baird
Subscribe for More Information
06:11 EDTGMEGameStop downgraded to Market Perform from Outperform at Telsey Advisory
Subscribe for More Information
05:57 EDTGMEStocks with implied volatility above IV index mean; DG GME
Subscribe for More Information
November 20, 2014
18:21 EDTGMEOn The Fly: After Hours Movers
Subscribe for More Information
16:06 EDTGMEGameStop drops 12% to $38.64 after Q3 results miss expectations
16:05 EDTGMEGameStop sees FY14 EPS $3.40-$3.55, consensus $3.68
Subscribe for More Information
16:04 EDTGMEGameStop sees Q4 EPS $2.08-$2.24, consensus $2.28
GameStop said that based on several titles being moved out of 2014 and the current sales trends of prior gen software, it is narrowing its previous guidance. For Q4, GameStop expects comparable store sales to range from down 5.0% to up 2.0%. Diluted earnings per share are expected to range from $2.08-$2.24, consensus $2.28.
16:03 EDTGMEGameStop reports Q3 adjusted EPS 57c, consensus 61c
Reports Q3 revenue $2.09B, consensus $2.2B. Consolidated comparable store sales dropped 2.3%. GME said topline and comparable store sales were negatively impacted by the delayed release of Assassinís Creed Unity.
15:28 EDTGMENotable companies reporting after market close
Subscribe for More Information
15:20 EDTGMEGameStop technical comments ahead of results
Subscribe for More Information
07:19 EDTGMEGameStop November volatility elevated into Q3 and outlook
Subscribe for More Information
06:35 EDTGMEStocks with implied volatility above IV index mean; BBY GME
Subscribe for More Information
November 19, 2014
13:24 EDTGMEGameStop November volatility elevated into Q3 and outlook
Subscribe for More Information
10:47 EDTGMEStocks with call strike movement; GME GMCR
GameStop (GME) December 55 call option implied volatility increased 4% to 55, Green Mountain (GMCR) December 185 call option implied volatility increased 3% to 54 according to IVolatility.
08:44 EDTGMEGameStop Q3 results should be solid, holiday sales the focus, says RW Baird
Subscribe for More Information
07:35 EDTGMEGameStop November volatility elevated into Q3 and outlook
Subscribe for More Information
November 18, 2014
05:55 EDTGMEStocks with implied volatility above IV index mean; GME LULU
Subscribe for More Information
November 17, 2014
08:28 EDTGMEGameStop Q3 results should be at high end of guidance, says Wedbush
Subscribe for More Information
07:08 EDTGMEGameStop November volatility elevated into Q3 and outlook
Subscribe for More Information
06:05 EDTGMEStocks with implied volatility above IV index mean; GME LULU
Subscribe for More Information
1 | 2 | all recent GME news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use